Shannon Bean, Ms Email & Phone Number

Brunswick, ME, US

Dedicated to a comprehensive range of responsibilities that encompass the entire investment lifecycle; identifying potential deals, conducting thorough due diligence, and sealing transactions. Furthermore, nurturing of portfolio companies, providing mentorship, and shaping both strategic direction and fundraising initiatives. **If you’re a startup seeking.

Langdon, NH, US

Provide growth strategy support.email: sbean@motheroffact.com

US, US

Provide growth strategy support.email: shannon@flyparrots.com

New York, New York, US

As an Expert, I provide strategic advice and guidance to founders and operators within the Primary portfolio and broader network. Experts enjoy access to early-stage businesses, emerging trends and technology, and an expanded network of exceptional leaders and resources through a top-tier seed-stage firm.Primary is New York City’s premier early-stage.

Mountain View, WY, US

Creating an innovative intelligent infrastructure through Human-Computer Interaction (HCI) across multiple industries, driving growth strategy & product.

Secaucus, NJ, US

Previously a member of Quest’s Healthcare Analytics Solutions ("HAS") Leadership Team, I was responsible for driving the formation of strategic partnerships that resulted in bringing technology, data, domain expertise, enhancements and/or channels together which were critical elements of driving the business growth strategy and product development. ·.

Belfast, Northern Ireland, GB

• Directed end-to-end global (Americas, EU, APAC, ROW) business and corporate development processes by leading pre-and post-partnership activities and identifying nexus of opportunities to strategically grow and support.
• Produced 80+ partnership proposals (range of $100 K – $2 MM), teasers and capability presentations for clients, investors, and board of directors
• Generated and negotiated contracting documents (CDA, MSA, SOW/Work Orders); resulted in $12+MM
• Played a key role in supporting product launch, DXRX - the world’s first diagnostic network for precision medicine
• Developed partnership strategy and execution plans to identify, target and close new business opportunities (e.g. J.P.Morgan Healthcare San Francisco 2020, Virtual ASCO 2020, etc) resulting in forged relationships.
• Evaluated pharma pipelines (oncology and general medicine biomarkers), technologies, and products that represent near-term commercial opportunities and streamed-lined operations between internal and external.

Lake Forest, IL, US

• Executed business development efforts to guide senior leadership in its external partnering and licensing strategies and managed ongoing business relationships with Assertio's alliance partners. Evaluated business and.
• Identified target partners for in- and out-licensing, M&A, or commercial partnerships. Resulted in acquisition of five marketed products from Iroko Pharmaceuticals, Inc. (Iroko); SoluMatrix® NSAIDs: VIVLODEX®.
• Supported M&A teams in evaluating financial feasibility of potential acquisitions using valuation analyses i.e., DCF
• Steered the M&A integration process of Iroko’s products between signing and closing. Resulted in efficient and streamlined transition of products by partnering with Finance, Accounting, Commercial, Legal, Manufacturing.
• Managed relationships with alliance partners for SPRIX® (ketorolac tromethamine), OraPharma and Ascend Therapeutics to ensure partners were on track to meet contractual obligations and milestones
• Evaluated business and scientific merits of new therapeutic indications

Rochester, New York, US

• (Formerly, High Tech Rochester) Managed the NYSERDA EIR Program under Governor Andrew Cuomo’s administration, a statewide mentoring program for companies in various stages. Evaluated 35+ life science, clean-energy, and.
• Managed strategic partnerships with NYSERDA, university accelerators, companies and EIRs
• Increased business development efforts by a factor of 3X, engaging with various stakeholders across the entrepreneurial ecosystems in the US
• Led and managed 60 EIRs and 35+ companies following a strategic vetting process implemented to sustain ultimate goal; a world class EIR program
• Accelerated company growth by connecting EIRs with new companies in short-term, highly focused strategic and consulting engagements
• Developed and negotiated engagement contracts and produced quarterly and annual reports for Governor Cuomo's administration

Rochester, New York, US

• Multifaceted role actively in the management of deal flow, due-diligence investment negotiations for over 50 life science, health, SaaS, clean energy, and tech investment opportunities.
• Made investment recommendations to managing partners resulting in over $1.2MM total investments as either convertible debt or equity
• Advised panel discussions of entrepreneurs connected to various universities
• Assisted companies who were in deep due diligence with strategic direction, business development and P&L forecast models
• Assigned as relationship builder at events/meetings to develop regional and national partnerships for the firm in upstate New York
• Trained junior analysts by directing new hires in performing due diligence; led to increased efficiency, effective evaluations and investment direction

Bar Harbor, ME, US

• Conducted research on the genetic basis of aging and age-associated kidney disease using both C. elegans and mouse model systems under Drs. Ron Korstanje and George Sutphin.
• Co-authored “Caenorhabditis elegans orthologs of human genes differently expressed with age are enriched for determinants of longevity” in Aging Cell (2017) pp1-11, Doi:10.1111/acel.12595
• Managed and analyzed data for verbal/written presentations and publications
• Maintained animals, harvested tissue samples for analysis and utilized molecular techniques such as PCR/western blotting

New Brunswick, NJ, US

• Ortho Clinical Diagnostics part of the J+J umbrella of companies: Oversaw validation of CellSearch, a Circulating Tumor Cell (CTC) test product, currently used in monitoring patients with metastatic breast, colorectal.
• Assisted in product development and troubleshooting protocols - product sales for the CTC platform reached over $30MM in 2014
• Maintained primary mammalian cell culture on PC39 and SkBr3 cells
• Presented findings to Director of R&D that contributed in product launch

Bar Harbor, ME, US

• Investigated the genetic basis for immune tolerance to endogenous proteins and the defects in these mechanisms that lead to type I diabetes.
• Presented findings to over 200 people including the President and CEO, leadership team, trustees, donors and other prestigious individuals
• Participated in cultivation events and formed meaningful relationships with trustees and JAX National Council
• Managed experimental mice and common isolation techniques (e.g., dendritic cells isolation)

Master Of Science (M.S.), Service Leadership & Innovation, Concentration: Entrepreneurship & Service Systems

The Roux Institute At Northeastern University, Graduate Certificate In Applied Analytics

Bachelor Of Science (B.S.), Biotechnology